First psychedelic-assisted PTSD therapy delayed by FDA CRL to Lykos BioWorld Onlinesource Post navigation Psychedelic Medicine Has a Therapy Problem – The AtlanticPsychedelic drug contender stocks drop after FDA rejects MDMA treatment – MarketWatch